Blog
RSS FeedPosted by Michael Wonder on 08 Jul 2016
Novartis announces FDA approval of Xolair (omalizumab) for paediatric allergic asthma
7 July 2016 - Extension of indication makes Xolair the first and only approved biologic for pediatric patients six years and ...
Posted by Michael Wonder on 01 May 2016
Teva announces FDA approval of ProAir RespiClick (salbutamol sulphate) inhalation powder for paediatric asthma patients ages 4 to 11
29 April 2016 - Teva Pharmaceuticals announced today that the U.S. FDA has approved ProAir RespiClick (salbutamol sulphate) inhalation powder for ...
Posted by Michael Wonder on 23 Mar 2016
FDA approves Cinqair to treat severe asthma
23 March 2016 - The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for ...
Posted by Michael Wonder on 05 Nov 2015
FDA approves Nucala to treat severe asthma
4 November 2015 - The U.S. FDA has approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment ...